Product Images Daliresp
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Daliresp NDC 0310-0088 by Astrazeneca Pharmaceuticals Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structural Formula - dal00 0006 01
daliresp 500 mcg 30 count tablets
This is a medication information label for a drug called "Daliresp" which comes in tablet form with a strength of 20mg (roflumilast). It is manufactured by AstraZeneca and comes in a bottle with 30 tablets. Each tablet contains 500mcg of the active ingredient. The label recommends dispensing the medication guide to each patient along with the medication.*
dalriesp 250 mcg 28 day pack
The text provides information about a medicine called "Daliresp" or "roflumilast" which comes in a package containing 28 tablets that is child-resistant. The tablets are produced by AsfraZeneca.*
figure 1
This is a list of drugs indicating whether they require caution, dose adjustment or are not recommended for use with Roflumilast or Roflumilast N-oxide based on the change in Cmax (maximum concentration) and AUC (area under the concentration-time curve) values. Some drugs like budesonide, Digoxin, Formoterol, Maalox, Midazolam, Montelukast, Salbutamol, sildenafil, Theophylline and Warfarin do not require any dose adjustment. However, Rifampicin is not recommended for use with Roflumilast.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.